• SENSEX 77,540.83
    3.11 (+0.00%)
  • BANKNIFTY 57,761.95
    266.05 (+0.46%)
  • HDFC Bank
    732.85 1,020.35(%)
  • Welspun Corp
    2,348.30 2,348.30(%)
  • 360 ONE
    1,190.00 906.20(%)
  • Shadowfax Technologies
    259.85 268.55(%)
  • Hyundai Motor I
    2,210.85 1,658.45(%)
  • Netweb Technol.
    5,675.00 5,675.00(%)
  • Dhoot Transmission
    1,523.85 1,523.85(%)
  • KDDL Ltd
    4,065.00 4,150.00(%)
  • N S D L
    839.00 1,382.00(%)
  • Deepak Nitrite
    1,726.00 1,280.40(%)
  • Pine Labs
    156.25 134.75(%)
  • Balrampur Chini
    714.30 393.40(%)
  • Radico Khaitan
    4,613.30 2,504.60(%)
  • Interglobe Aviat
    5,053.75 3,894.80(%)
  • Hindustan Copper
    581.00 759.20(%)
  • Cupid
    287.95 298.95(%)
  • HDFC AMC
    2,596.70 2,206.05(%)
  • Himadri Special
    650.25 420.00(%)
  • Meesho
    204.40 125.70(%)
  • Shiprocket
    136.72 129.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Venus Remedies Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4791.0
  • ISIN : INE411B01019
1,738.10 -28 (-1.56%)
  • As on 21 Aug 2026 (EOD)

  • Today’s Low

    1,715.30

  • Today’s High

    1,764.50

  • Open

    1,715.30

  • Perv Close

    1,765.60

  • 52W Low

    424.00

  • 52W High

    2,044.30

Key Indicators

  • P/E(TTM)

    20.44

  • Mar.Cap (₹Cr.)

    2,323.32

  • Div & Yield %

    0.58

  • Book Value(₹)

    515.92

  • Debt-Equity Ratio

    -1.56

  • AGM Date

    21-Aug-2026

  • EPS

    84.64

  • P/E Ratio

    20.44

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    2,323.32

  • RONW (%)

    6.01

  • ROCE (%)

    8.52

Score Board

  • Equity (₹ in Cr.)

    13.37

  • BV (₹)

    515.90

  • Sales( ₹ in Cr.)

    768.73

  • NP (in Cr.)

    99.31

  • NP Var(%)

    123.0

  • Div%

    100.0

  • CPS (₹)

    92.80

  • EPS (₹)

    74.30

  • Traded Value (₹ in Lakhs)

    2,357.47

  • 52 Week High

    2,044.30

  • 52 Week Low

    424.00

  • Price BSE

    1764.0

  • Price NSE

    1,766.00

  • Market Capital( in Cr.)

    2,357.47

  • P/C Ratio

    19.00

  • P/E Ratio

    23.70

  • Price Vs.BV

    74.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 639.46 575.21 537.66 576.71 514.62 320.23
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 639.46 575.21 537.66 576.71 514.62 320.23
Other Income 30.69 11.32 10.17 8.43 50.37 34.93
Stock Adjustments -0.93 5.00 -14.26 -3.19 7.36 -6.21
Total Income 669.22 591.53 533.57 581.95 572.35 348.95
EXPENDITURE :            
Raw Materials 373.86 357.22 322.44 374.31 344.04 170.60
Power and Fuel Cost 4.91 4.99 4.17 3.78 3.39 3.41
Employee Cost 67.21 57.57 47.67 43.75 35.89 33.79
Other Manufacturing Expenses 12.34 10.07 6.18 6.47 4.51 3.63
Selling and Administration Expenses 109.58 89.17 81.16 76.40 87.29 59.53
Miscellaneous Expenses 0.64 0.31 0.26 0.00 9.17 40.16
Employee Benefit Expenses 67.21 57.57 47.67 43.75 35.89 33.79
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 568.54 519.33 461.88 504.71 484.28 311.12
Operating Profit 100.69 72.21 71.70 77.25 88.07 37.84
Interest 0.00 0.00 0.00 0.00 12.73 13.05
Gross Profit 100.69 72.21 71.70 77.25 75.34 24.79
Depreciation 21.62 25.55 31.37 32.58 34.28 31.05
Profit Before Tax 79.07 46.66 40.33 44.67 41.06 -6.26
Current Tax 21.86 12.22 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.65 3.93 11.36 -4.32 -13.21 1.96
Reported Net Profit 52.56 30.50 28.96 48.99 54.27 -8.23
Extraordinary Items 8.10 0.37 0.01 0.00 23.44 -6.85
Adjusted Net Profit 44.46 30.13 28.95 48.99 30.83 -1.38
Adjustment below Net Profit -0.48 -0.19 -0.46 0.24 -0.10 -0.47
P & L Balance brought forward 195.07 164.76 136.26 87.02 32.85 41.55
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 247.15 195.07 164.76 136.26 87.02 32.85
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 39.32 22.82 21.67 36.65 43.97 -6.67
Earnings Per Share(Adj)-Unit Curr 39.32 22.82 21.67 36.65 43.97 -6.67
Book Value 441.01 380.48 357.63 336.21 313.10 269.21
Book Value(Adj)-Unit Curr 441.01 380.48 357.63 336.21 313.10 269.21

Shareholding Pattern

  • Promoter Group

    41.76%

  • Public Share Holding

    58.24%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,300,000 17.21 2,300,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,281,997 24.55 3,281,997 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,581,997 41.76 5,581,997 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 390,228 2.92 390,228 36
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 118,649 0.89 118,649 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 508,877 3.81 508,877 41
2] Non Institution
Bodies Corporate 397,709 2.98 397,409 151
Clearing Members 59,496 0.45 59,496 27
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 214,128 1.60 214,128 489
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 259,414 1.94 259,414 538
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,737,102 13.00 1,737,102 33
Individuals holding nominal share capital up to Rs. 1 lakh 4,186,465 31.32 4,085,423 20,596
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 133,841 1.00 133,841 1
Sub Total 7,276,114 54.43 7,174,772 21,859
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,366,988 100.00 13,265,646 21,905

Company Background

Venus Remedies LtdPharmaceuticals - Indian - Formulations

  • Venus Remedies Ltd
  • BSE Code : 4791.0
  • ISIN : INE411B01019

  • Incorporation Year

    1989

  • Registered Office

    S C No 857 Cabin No 10 2nd Flr
    N A C Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

  • FAX

  • Chairman

    Pawan Chaudhary

  • Managing Director

    Pawan Chaudhary

  • Company Secretary

    Neha Arora

  • Auditor

    J K Jain & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Venus Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Venus Remedies 1,730.40 660.24 639.46 20.44 11.75
Abbott India 26,245.55 7,217.19 6,929.05 34.54 43.78
Astrazeneca Phar 7,410.50 2,304.07 2,275.58 109.22 27.86
Glaxosmi. Pharma 2,899.60 3,932.76 3,790.20 46.32 58.17
Cipla 1,426.20 20,102.60 18,979.95 37.48 13.88
Novartis India 1,423.40 398.23 356.27 35.94 16.64
Bliss GVS Pharma 582.25 773.53 729.81 54.06 12.51
Amrutanjan Healt 536.60 469.50 451.82 28.74 21.89
Fermenta Biotec. 478.20 474.15 450.25 22.32 18.77
Guj. Themis Bio. 380.90 152.47 150.80 85.21 27.21
Ambalal Sarabhai 45.28 19.52 3.94 83.85 6.77